{"id":"W4411027625","doi":"10.1200/jco.2025.43.17_suppl.lba3","title":"Results from VERIFY, a phase 3, double-blind, placebo (PBO)-controlled study of rusfertide for treatment of polycythemia vera (PV).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Protagonist Therapeutics","keywords":"Medicine; Polycythemia vera; Placebo; Double blind; Internal medicine; Pharmacology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00385568,0.001234881,0.002489625,0.0003142321,0.000489788,0.0008991246,0.0006495218,0.001445483,0.00993694],"category_scores_gemma":[0.002619988,0.0004862408,0.001232563,0.0003741953,0.0005799631,0.0008698534,0.000311668,0.001694158,0.000942203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003830575,"about_ca_system_score_gemma":0.001406405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005288301,"about_ca_topic_score_gemma":0.001927748,"domain_scores_codex":[0.9990411,0.0005179166,0.00009876626,0.0001257134,0.0001210208,0.00009543658],"domain_scores_gemma":[0.9984491,0.0005652456,0.0004155913,0.00008715622,0.0001602715,0.0003225065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9399856,0.01007851,0.001436929,0.002627515,0.001709155,0.00009099284,0.00008985808,0.0003901448,0.009964245,0.0001987476,0.003872992,0.02955528],"study_design_scores_gemma":[0.8415717,0.1347718,0.01378906,0.0002051886,0.002357014,0.0001749178,0.00004662311,0.0003718714,0.002031367,0.000201948,0.004441191,0.00003738934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9168548,0.02127263,0.00322841,0.001347284,0.0007275602,0.02126978,0.0199119,0.0005495575,0.01483814],"genre_scores_gemma":[0.9692152,0.005871149,0.003342062,0.001832098,0.000412275,0.008075837,0.007245964,0.0001003987,0.003905024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00993694,"threshold_uncertainty_score":0.03324234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2153715444892411,"score_gpt":0.5330535497673295,"score_spread":0.3176820052780885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}